Medication info
Cozaar XQ Tablet 5/50 Milligrams

Cozaar XQ Tablet 5/50 Milligrams

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tabletAmlodipine Camsylate›7.84mg / 1 tablet
Manufacturer / importer
Korea Organon Co., Ltd.
Appearance
White rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200908185 · Approved 2009.11.20 · Insurance code 073100030

Summary

Main use
Treatment of essential hypertension; initial therapy for stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose of each individual component (amlodipine or losartan) be adjusted before starting this medicine. However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50milligrams once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular effective blood volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective blood volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: For patients 75 years of age and older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
∘ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, use of this medicine is not recommended.

Ingredients

Manufacturer
Korea Organon Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; initial therapy for stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medication is used for patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy using amlodipine or losartan. It is also used as initial therapy for stage 2 hypertension patients who require combination therapy to reach the target blood pressure. Therefore, it is effectively used as a treatment for blood pressure control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose of each individual component (amlodipine or losartan) be adjusted before starting this medicine. However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50milligrams once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular effective blood volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective blood volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: For patients 75 years of age and older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

∘ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, use of this medicine is not recommended.

Precautions

This medication can cause severe damage to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. There may be symptoms of hypotension when this medication is first administered, so patients with reduced blood volume or those on diuretics need to evaluate their condition carefully before taking this medication. Patients with hypersensitivity to any component of this drug, severe liver disease, severe aortic stenosis, shock, diabetes, or severe renal impairment should not take this medication. Patients with reduced blood volume or those on strict sodium restrictions, moderate to severe renal impairment, hyperkalemia, and those on specific blood pressure medications should be careful. Possible side effects include dizziness, headache, drowsiness, edema, itching, palpitations, orthostatic hypotension, and dyspnea, so if any unusual symptoms occur, consult with medical personnel. Caution should be exercised when administering to elderly patients or children as safety and efficacy have not been adequately established. When used in conjunction with other blood pressure medications or certain drugs, the efficacy may be enhanced or the risk of side effects may increase, so any currently taken medications should be disclosed. This medication can abruptly lower blood pressure, so caution is necessary during dangerous machinery operation, such as working at heights or driving. Women who are pregnant or may become pregnant should not take this medication, and it should be avoided during breastfeeding. In case of overdose, severe hypotension, tachycardia, and shock may occur, so the dosage must be strictly adhered to. If an overdose is suspected, contact a medical institution immediately. Store this medication out of reach of children, and it is better not to transfer it to another container to maintain its quality.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
Show 230 more
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • conjunctival injection
  • frequent urination
  • arthralgia
  • sleep apnea syndrome
  • uterine fibroids
  • uterine prolapse
  • hyperlipidemia
  • osteoporosis
  • diabetes
  • gastric ulcer
  • hypoglycemia
  • herpes zoster
  • hypercholesterolemia
  • unspecified lipid metabolism disorder
  • atherosclerosis
  • pulmonary edema
  • pneumonia
  • periodontal destruction
  • benign gastrointestinal neoplasm
  • gastric cancer
  • cholelithiasis
  • cholangitis
  • liver cirrhosis
  • fracture
  • ligament disorder
  • albuminuria
  • chronic renal failure
  • exacerbation of chronic renal failure
  • renal papillary necrosis
  • prostatic hyperplasia
  • ovarian cysts
  • cataract
  • temperature sensation changes
  • fatigue
  • edema
  • dizziness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain
  • weight loss
  • hypotension
  • vasculitis
  • tension headache
  • sensory decrease
  • dysesthesia
  • peripheral neuropathy
  • syncope
  • dysgeusia
  • tremor
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased frequency of urination
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • skin rash
  • maculopapular rash
  • dizziness
  • heat sensation
  • decreased glucose tolerance
  • weakness
  • myocardial infarction
  • arrhythmia
  • chest pain
  • hypotension
  • sinus node block
  • atrioventricular block
  • precordial pain
  • diarrhea
  • loose stools
  • skin rash
  • maculopapular rash
  • dizziness
  • heat sensation
  • decreased glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory infection
  • sinusitis
  • diarrhea
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • fatigue
  • swelling
  • abdominal pain
  • vascular edema
  • skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • arm pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory diminution
  • decreased libido
  • memory impairment
  • migraine
  • neural hypersensitivity
  • panic disorder
  • sleep disorders
  • tremors
  • dizziness
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • petechial bleeding
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning and pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • vision loss
  • erectile dysfunction
  • urethral infection
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • vascular edema
  • vasculitis
  • anaphylactic reaction
  • hepatitis
  • liver dysfunction
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • dysgeusia
  • dry cough
  • erythroderma
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • elevated liver enzymes
  • hypotension
  • tachycardia
  • non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly closed container. It is advisable to keep the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This way, the effectiveness of the medication can be maintained for a longer period.

Appearance and packaging

Appearance

White rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.